Programs identify therapies and integrate molecular techniques in clinical trials for solid tumors, especially prostate cancer, and hematological cancers. Strict links to IOSI, SAKK or IELSG cooperative groups. IOR also owns the patent of novel anticancer molecules.

Location

Via Vincenzo Vela 6, 6500 Bellinzona, Switzerland

Facts & figures
  • Type of organization

    Foundation

  • Year of foundation

    2003

  • Number of employees in Switzerland

    50-149

Key business
Core competencies